Here are five things to know:
1. The company issued 504,538 common shares at $1.35 per share.
2. The aggregate gross proceeds are CDN $681,126.
3. Proceeds from the offering will be used for general working capital purposes.
4. Director James Snow directly or indirectly subscribed for 84,444 common shares under the offering; Director David Rosenkrantz subscribed to 112,000.
5. The common shares issued under the offering are subject to a four-month hold period expiring May 10, 2015.
More articles on orthopedic devices:
8 trends in the biocompatible materials market
K2M revenue up 18% in 2014—5 things to know
Could Congress repeal the medical device tax without Obama? 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
